US EditionPepto Bismol May Not Prevent Traveler’s Diarrhea, New Study Finds
- The CDC led a study finding that Pepto Bismol's active ingredient did not reduce traveler’s diarrhea in 270 adults traveling to Asia and Africa.
- Many travelers use Pepto Bismol off-label to prevent diarrhea, but this study, despite not reaching its participant target, tested this prevention claim.
- Participants were given either bismuth subsalicylate—administered as four tablets two times daily—or a placebo throughout trips lasting one to three weeks, with information gathered via questionnaires.
- On May 29, the researchers published findings indicating no significant difference in diarrhea episodes between the treatment and control groups, while suggesting that a larger study could potentially reveal a modest benefit.
- The findings represent the initial updated evidence on the preventive use of bismuth subsalicylate since the 1980s and indicate that healthcare professionals might need to reconsider recommending Pepto Bismol for diarrhea prevention, while additional research remains necessary.
Insights by Ground AI
Does this summary seem wrong?
33 Articles
33 Articles
All
Left
8
Center
7
Right
2
Daily Journal+28 Reposted by 28 other sources
Pepto Bismol May Not Prevent Traveler’s Diarrhea, New Study Finds
Key Takeaways
·Cherokee County, United States
Read Full Article
Coverage Details
Total News Sources33
Leaning Left8Leaning Right2Center7Last UpdatedBias Distribution47% Left
Bias Distribution
- 47% of the sources lean Left
47% Left
L 47%
C 41%
12%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
